Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,615 | 13,302 | 16,850 | 10,488 | 13,311 |
| TOTAL | $11,386 | $14,752 | $18,184 | $11,093 | $13,952 |
| Non-Current Assets | |||||
| PPE Net | 435 | 462 | 493 | 517 | 543 |
| Other Non-Current Assets | 430 | 445 | 460 | 939 | 559 |
| TOTAL | $865 | $907 | $952 | $1,456 | $1,102 |
| Total Assets | $12,251 | $15,659 | $19,136 | $12,549 | $15,054 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,664 | 2,875 | 2,528 | 2,055 | 1,544 |
| Other current liabilities | N/A | N/A | 46 | 47 | 43 |
| TOTAL | $2,770 | $2,978 | $2,674 | $2,200 | $1,622 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 33 |
| Other Non-Current Liabilities | 422 | 450 | 476 | 502 | 171 |
| TOTAL | $422 | $450 | $476 | $502 | $171 |
| Total Liabilities | $3,191 | $3,428 | $3,150 | $2,702 | $1,793 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31 | 31 | 31 | 18 | 16 |
| Retained earnings | -111,681 | -108,301 | -104,398 | -101,210 | -97,588 |
| TOTAL | $9,059 | $12,231 | $15,986 | $9,847 | $13,261 |
| Total Liabilities And Equity | $12,251 | $15,659 | $19,136 | $12,549 | $15,054 |